Kelley L. Colvin

1.0k total citations
26 papers, 702 citations indexed

About

Kelley L. Colvin is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Kelley L. Colvin has authored 26 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Immunology. Recurrent topics in Kelley L. Colvin's work include Pulmonary Hypertension Research and Treatments (16 papers), Neonatal Respiratory Health Research (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Kelley L. Colvin is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Neonatal Respiratory Health Research (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Kelley L. Colvin collaborates with scholars based in United States, Norway and Saudi Arabia. Kelley L. Colvin's co-authors include Michael E. Yeager, D. Dunbar Ivy, Kurt R. Stenmark, Dmitry Belchenko, Ivan F. McMurtry, Sarah A. Gebb, Shinichi Takatsuki, Cheryl E. Gariepy, Masashi Yanagisawa and Masahiko Oka and has published in prestigious journals such as Circulation, Circulation Research and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Kelley L. Colvin

26 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelley L. Colvin United States 15 460 228 138 115 93 26 702
Harley R. Powell Australia 14 215 0.5× 119 0.5× 253 1.8× 206 1.8× 67 0.7× 27 984
Gerald M. Mahon United States 3 538 1.2× 234 1.0× 176 1.3× 81 0.7× 76 0.8× 3 667
Robertas Scerbavicius United States 9 515 1.1× 135 0.6× 205 1.5× 93 0.8× 136 1.5× 9 869
Katsuo Sueishi Japan 9 182 0.4× 159 0.7× 150 1.1× 139 1.2× 149 1.6× 13 620
Alexandra Buehler Germany 10 185 0.4× 341 1.5× 178 1.3× 129 1.1× 32 0.3× 10 772
Jeremy Ben‐Shoshan Israel 17 125 0.3× 378 1.7× 183 1.3× 179 1.6× 39 0.4× 59 889
R.R. Bunge United States 10 306 0.7× 266 1.2× 91 0.7× 80 0.7× 43 0.5× 14 687
Anthony Rousselle Germany 10 177 0.4× 141 0.6× 285 2.1× 58 0.5× 58 0.6× 16 703
Arne Yndestad Norway 13 123 0.3× 166 0.7× 139 1.0× 58 0.5× 34 0.4× 19 608

Countries citing papers authored by Kelley L. Colvin

Since Specialization
Citations

This map shows the geographic impact of Kelley L. Colvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelley L. Colvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelley L. Colvin more than expected).

Fields of papers citing papers by Kelley L. Colvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelley L. Colvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelley L. Colvin. The network helps show where Kelley L. Colvin may publish in the future.

Co-authorship network of co-authors of Kelley L. Colvin

This figure shows the co-authorship network connecting the top 25 collaborators of Kelley L. Colvin. A scholar is included among the top collaborators of Kelley L. Colvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelley L. Colvin. Kelley L. Colvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colvin, Kelley L., Kristine Wolter‐Warmerdam, Francis Hickey, & Michael E. Yeager. (2024). Altered peripheral blood leukocyte subpopulations, function, and gene expression in children with Down syndrome: implications for respiratory tract infection. European Journal of Medical Genetics. 68. 104922–104922. 1 indexed citations
2.
Colvin, Kelley L., et al.. (2023). Increased lethality of respiratory infection by Streptococcus pneumoniae in the Dp16 mouse model of Down syndrome. FASEB BioAdvances. 5(12). 528–540. 1 indexed citations
3.
Colvin, Kelley L., Kathleen Nguyen, Robert J. Elliott, et al.. (2023). Lung and Heart Biology of the Dp16 Mouse Model of down Syndrome: Implications for Studying Cardiopulmonary Disease. Genes. 14(9). 1819–1819. 3 indexed citations
4.
Gally, Fabienne, et al.. (2017). The TRPM2 ion channel contributes to cytokine hyperproduction in a mouse model of Down Syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(1). 126–132. 4 indexed citations
5.
Colvin, Kelley L. & Michael E. Yeager. (2017). What people with Down Syndrome can teach us about cardiopulmonary disease. European Respiratory Review. 26(143). 160098–160098. 75 indexed citations
6.
Colvin, Kelley L. & Michael E. Yeager. (2015). Applying Biotechnology and Bioengineering to Pediatric Lung Disease: Emerging Paradigms and Platforms. Frontiers in Pediatrics. 3. 45–45. 1 indexed citations
7.
Colvin, Kelley L., et al.. (2015). Biomarkers for pediatric pulmonary arterial hypertension: challenges and recommendations. Paediatric Respiratory Reviews. 16(4). 225–231. 11 indexed citations
8.
Colvin, Kelley L. & Michael E. Yeager. (2014). Proteomics of pulmonary hypertension: Could personalized profiles lead to personalized medicine?. PROTEOMICS - CLINICAL APPLICATIONS. 9(1-2). 111–120. 11 indexed citations
9.
Colvin, Kelley L.. (2014). Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease. Journal of Pulmonary & Respiratory Medicine. 4(4). 57 indexed citations
10.
Colvin, Kelley L., et al.. (2014). Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate. Frontiers in Pediatrics. 2. 7–7. 32 indexed citations
11.
Colvin, Kelley L., et al.. (2013). Bronchus-associated Lymphoid Tissue in Pulmonary Hypertension Produces Pathologic Autoantibodies. American Journal of Respiratory and Critical Care Medicine. 188(9). 1126–1136. 63 indexed citations
12.
Colvin, Kelley L., Kurt R. Stenmark, & Michael E. Yeager. (2013). Right ventricular lymphatic insufficiency is associated with increased edema in pulmonary hypertension. European Respiratory Journal. 42(Suppl 57). 1499–1499. 1 indexed citations
13.
Yeager, Michael E., et al.. (2012). Activation of the Unfolded Protein Response is Associated with Pulmonary Hypertension. Pulmonary Circulation. 2(2). 229–240. 40 indexed citations
14.
Yeager, Michael E., et al.. (2012). Loss Of Tolerance Associated With Bronchus Associated Lymphoid Tissue Expansion In Pulmonary Hypertension. A4761–A4761. 1 indexed citations
15.
Yeager, Michael E., Dmitry Belchenko, Kelley L. Colvin, et al.. (2011). Circulating fibrocytes are increased in children and young adults with pulmonary hypertension. European Respiratory Journal. 39(1). 104–111. 45 indexed citations
16.
Yeager, Michael E., et al.. (2011). Endothelin-1, the Unfolded Protein Response, and Persistent Inflammation. American Journal of Respiratory Cell and Molecular Biology. 46(1). 14–22. 69 indexed citations
17.
Yeager, Michael E., Dmitry Belchenko, Kelley L. Colvin, et al.. (2011). Circulating Myeloid-Derived Suppressor Cells Are Increased and Activated in Pulmonary Hypertension. CHEST Journal. 141(4). 944–952. 37 indexed citations
18.
Ivy, D. Dunbar, Ivan F. McMurtry, Kelley L. Colvin, et al.. (2005). Development of Occlusive Neointimal Lesions in Distal Pulmonary Arteries of Endothelin B Receptor–Deficient Rats. Circulation. 111(22). 2988–2996. 52 indexed citations
19.
Cook, James L., et al.. (1999). E1A Oncogene Induction of Cellular Susceptibility to Killing by Cytolytic Lymphocytes Through Target Cell Sensitization to Apoptotic Injury. Experimental Cell Research. 251(2). 414–423. 18 indexed citations
20.
Cook, James L., et al.. (1999). E1A Oncogene-Induced Cellular Sensitization to Immune-Mediated Apoptosis Is Independent of p53 and Resistant to Blockade by E1B 19 kDa Protein. Experimental Cell Research. 252(1). 199–210. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harley R. Powell Breakdown of academic impact, for papers by Gerald M. Mahon Breakdown of academic impact, for papers by Robertas Scerbavicius Breakdown of academic impact, for papers by Katsuo Sueishi Breakdown of academic impact, for papers by Alexandra Buehler Breakdown of academic impact, for papers by Jeremy Ben‐Shoshan Breakdown of academic impact, for papers by R.R. Bunge Breakdown of academic impact, for papers by Anthony Rousselle Breakdown of academic impact, for papers by Arne Yndestad
Rankless by CCL
2026